Nuvasive Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Nuvasive Inc's Inventory turnover ratio has remained unchanged compare to previous quarter at 1.01 in the second quarter 2023Average processing period, for Nuvasive Inc's inventories remained unchanged at 361 days, in the Jun 30 2023 quarter.

Within Healthcare sector 354 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 1062, from total ranking in the first quarter 2023 at 1615.

NUVA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nuvasive Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NUVA Inventory Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Inventory Growth	5.76 %	6.64 %	7.2 %	9.5 %	3.74 %
Y / Y Cost of Sales Growth	4.33 %	9.2 %	8.67 %	-8.78 %	9.55 %
Inventory Turnover Ratio (TTM)	1.01	1.01	1.01	1	1.05
NUVA's Total Ranking	# 1062	# 1615	# 1947	# 1262	# 1960
Average inventory processing period	361	360	362	364	347
Seq. Inventory Growth	1.4 %	2.17 %	-0.7 %	2.8 %	2.25 %
Seq. Cost of Sales Growth	3.59 %	-4.86 %	12.25 %	-5.7 %	8.42 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 153
Healthcare Sector	# 355
Overall Market	# 1062

Inventory Turnover Ratio Statistics
High	Average	Low
1.34	1.09	0.63
(Dec 31 2013)		(Dec 31 2011)

NUVA Company Profile >> Back to NUVA Efficiency Comparisons >> Compare NUVA Inventory Turnover Ratio to its Competitors

Financial Statements
Nuvasive Inc's Inventories	$ 351 Millions	Visit NUVA's Balance sheet
Nuvasive Inc's Cost of Revenues TTM	$ 347 Millions	Visit NUVA's Income Statement
What are NUVA's Sales?		Visit NUVA's Sales by Segment

Other Inventory Turnover Ratios
Nuvasive Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NUVA's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NUVA's Competitors
Inventory Turnover Ratio for NUVA's Suppliers
Inventory Turnover Ratio for NUVA's Customers

You may also want to know
NUVA's Sales Growth Rates	NUVA's Pe Price to earnings ratio	NUVA's Receivables Turnover Ratio	NUVA's Stock Quote
NUVA's Net Income Growth Rates	NUVA's Ps Price to Sales ratio	NUVA's Sales per Employee	NUVA's Asset Turnover Ratio
NUVA's Net Margin	NUVA's Pb Price to Book ratio	NUVA's Financial Strength Ratios	NUVA's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2023	Inventories at quarter ending Jun 30 2023
Merck and Co Inc	2.70	$ 15,765.000 Millions	$ 5,830 Millions
Strata Skin Sciences Inc	2.66	$ 13.547 Millions	$ 5 Millions
Viatris Inc	2.65	$ 9,428.600 Millions	$ 3,551 Millions
Perrigo Company Plc	2.65	$ 3,043.000 Millions	$ 1,147 Millions
Msa Safety Inc	2.64	$ 909.000 Millions	$ 344 Millions
Dariohealth Corp	2.64	$ 18.806 Millions	$ 7 Millions
Electromedical Technologies Inc	2.64	$ 0.298 Millions	$ 0 Millions
Acadia Pharmaceuticals Inc	2.63	$ 13.675 Millions	$ 5 Millions
Macrogenics Inc	2.59	$ 3.494 Millions	$ 1 Millions
Zynex inc	2.58	$ 36.320 Millions	$ 14 Millions
Evolus Inc	2.57	$ 53.718 Millions	$ 21 Millions
Embecta Corp	2.57	$ 367.900 Millions	$ 143 Millions
Akoya Biosciences Inc	2.56	$ 37.235 Millions	$ 15 Millions
Zeo Scientifix Inc	2.56	$ 0.644 Millions	$ 0 Millions
Livanova Plc	2.55	$ 351.064 Millions	$ 138 Millions
Amphastar Pharmaceuticals Inc	2.55	$ 264.630 Millions	$ 104 Millions
International Stem Cell Corporation	2.50	$ 3.363 Millions	$ 1 Millions
Pfizer Inc	2.49	$ 23,835.000 Millions	$ 9,586 Millions
Lifevantage Corp	2.47	$ 43.000 Millions	$ 17 Millions
Dynavax Technologies Corporation	2.45	$ 167.071 Millions	$ 68 Millions
Phibro Animal Health Corporation	2.45	$ 679.000 Millions	$ 278 Millions
Pressure Biosciences Inc	2.45	$ 2.013 Millions	$ 1 Millions
Silk Road Medical Inc	2.42	$ 45.813 Millions	$ 19 Millions
Biotricity Inc	2.41	$ 4.366 Millions	$ 2 Millions
Intuitive Surgical Inc	2.41	$ 2,216.600 Millions	$ 921 Millions
Bausch and Lomb Corp	2.40	$ 1,576.000 Millions	$ 657 Millions
China Pharma Holdings Inc	2.37	$ 8.009 Millions	$ 3 Millions
Standard Biotools Inc	2.35	$ 51.681 Millions	$ 22 Millions
Biolife Solutions Inc	2.33	$ 86.932 Millions	$ 37 Millions
Merit Medical Systems Inc	2.32	$ 643.951 Millions	$ 277 Millions

Date modified: 2026-09-12T06:12:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.